ArticleOpen forum infectious diseases2026
Mapping the Landscape of Endemic Mycoses in India: Insights From a Systematic Review of Reported Cases Spanning 6 Decades (1960-2025).
Article in Open forum infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Endemic mycoses are caused by fungi inhabiting specific ecological niches. These infections remain underreported due to diagnostic challenges and limited awareness. This study aims to provide a comprehensive synthesis of endemic mycoses in India, focusing on their distribution, clinical presentation, and outcomes. Method: A systematic literature search was conducted to identify Indian studies on proven endemic mycoses from 1960 to August 2025. Case reports, case series, and observational studies with laboratory-confirmed diagnosis of endemic mycoses were included, based on the European Organization for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium (EORTC/MSGERC) criteria. Probable and possible cases were excluded. Demographic, clinical, diagnostic, treatment, and outcome data were extracted and analyzed using descriptive statistics. Results: A total of 230 studies comprising 893 patients were included. Histoplasmosis (399, 44.7%), sporotrichosis (386, 43.2%), and talaromycosis (87, 9.7%) were the most common infections. Cases were reported from 28 Indian states and union territories. Histoplasmosis was widely distributed, whereas sporotrichosis was concentrated in sub-Himalayan belt, and talaromycosis in north-eastern India. Reports increased sharply after 2000, peaking during 2011-2020. Histoplasmosis and talaromycosis predominantly affected males and caused disseminated disease, whereas sporotrichosis showed female predominance and manifested as cutaneous forms. Human immunodeficiency virus (HIV) infection was strongly associated with talaromycosis. Misdiagnosis as tuberculosis occurred in 7.6% of cases. Mortality was highest in histoplasmosis and coccidioidomycosis. In histoplasmosis, amphotericin B followed by itraconazole reduced mortality significantly. Conclusions: Endemic mycoses in India are increasingly recognized, with distinct epidemiological and clinical patterns. Persistent misdiagnosis and varied outcomes emphasize the need for improved diagnostics, clinician awareness, and optimized antifungal treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.